A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients
- 31 December 1993
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 47 (2-3) , 73-78
- https://doi.org/10.1016/0753-3322(93)90294-u
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Detection of a common mutation of the catalase gene in Japanese acatalasemic patientsHuman Genetics, 1992
- Use of anti-CD3 monoclonal antibody in the generation of effector cells from human solid tumors for use in cancer biotherapyJournal of Immunological Methods, 1990
- Augmentation of cell number and LAK activity in peripheral blood mononuclear cells activated with anti-CD3 and interleukin-2Cancer Immunology, Immunotherapy, 1988
- Studies of serum-free culture medium in the generation of lymphokine activated killer cellsJournal of Immunological Methods, 1987
- T suppressor cell growth factor and anti-CD3 antibodies stimulate reciprocal subsets of T lymphocytes.The Journal of Experimental Medicine, 1987
- Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones.The Journal of Experimental Medicine, 1983
- Structure and expression of a cloned cDNA for human interleukin-2Nature, 1983